JOHNSON + JOHNSON DL 1JOHNSON + JOHNSON DL 1JOHNSON + JOHNSON DL 1

JOHNSON + JOHNSON DL 1

No trades
See on Supercharts

JOHNSON + JOHNSON DL 1 stock forum





Other MEDICAL sector stocks have related patterns, especially in last 6 months. ABT is one, but MDT (MedTronic) seems to me to be in very similar muliti-year situation despite increased earnings and revenues.
JNJ price was last so low in 2021.
From the fundamentals, it sure appears this stock is oversold, or perhaps there are factors hanging over this sector that I have not come to appreciate.
JNJ pays a respectable if not exciting dividend, as does MDT.

As several Motley Fool authors have recently written, these are companies to buy and to hold, seems like the next few years, and 2025especially is set up for some nice price appreciation, but when it will kick in is the question, the chart without historical context, does not look good.

JNJ is one of the stock you should look at for to buy. This dude haven’t been doing nothing much for the pass 3years. We might see massive bullish trend from 2025 onwards. Aiming for overall target of $180(100% fb level) to $220(fb extension level). Patience is the key, this might take yrs to happen. Longterm approach is the best!

JNJ have been consolidating for 2yrs plus since 2021. We might see a breakout of this trend to the upside in 2025. Massive bullish trend from top down Analysis perspective. Expect an all time all in 2025 if only it broke this weekly consolidation